Myogen (MYOG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myogen (MYOG)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (5)	12/19/2005 12:09:37 AM
From: tuck	Read Replies (2) of 50

Anybody here? Skepticism about the robustness of MYOG's recently announced Ambrisentan results can be found here: investorshub.com And track back a few replies to the PR. MYOG gave themselves an easier to treat population than ENCY gave themselves with Thelin? MOA is more or less the same, but receptor specificity may be different? I need to dig some more here. In any case, these guys seem to be pretty knowledgeable. I have no stake, but was looking at ENCY and Thelin. I am considering taking a stake in ENCY -- which conversely means I'm a bit bearish on MYOG, but that could change pending aforementioned digging. Instant answers and help appreciated as always. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next